Literature DB >> 2783906

RCBF-quantification with 99mTc-HMPAO-SPECT: theory and first results.

O Nickel1, B Nägele-Wöhrle, P Ulrich, D Eissner, A Roesler, W Grimm, K Hahn.   

Abstract

The activity concentrations of 99mTc-HMPAO in brain after intravenous injection were evaluated in 25 patients using SPECT. With additional first pass studies of heart and brain with the short lived isotope 195mAu, the cardiac output and the mean cerebral transit times of the patients were measured a short time before the HMPAO injection. The time dependence of 99mTc-HMPAO activity in the brain was registered during the first 5 min after injection over both hemispheres. Using a simplified three compartment model it was possible to calculate the mean retention fraction of HMPAO in brain from the time activity curves. It could be shown that the regional cerebral blood flow in ml/min per 100 g can be calculated from the activity concentration of HMPAO in the brain, the cardiac output and the retention fraction. In 15 of the 25 cases the rCBF was measured using the planar 133Xe inhalation method as a reference. We found a significant correlation between the mean hemisphere CBF from our method and the mean hemisphere grey matter CBF from the Xenon method with a correlation coefficient of 0.73.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2783906     DOI: 10.1007/BF00253591

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  12 in total

1.  Generalized scatter correction method in SPECT using point scatter distribution functions.

Authors:  P Msaki; B Axelsson; C M Dahl; S A Larsson
Journal:  J Nucl Med       Date:  1987-12       Impact factor: 10.057

2.  Serial studies of cerebral blood flow using 99Tcm-HMPAO: a comparison with 133Xe.

Authors:  A R Andersen; H Friberg; N A Lassen; K Kristensen; R D Neirinckx
Journal:  Nucl Med Commun       Date:  1987-07       Impact factor: 1.690

3.  The in vivo distribution of 99Tcm-HM-PAO in normal man.

Authors:  D C Costa; P J Ell; I D Cullum; P H Jarritt
Journal:  Nucl Med Commun       Date:  1986-09       Impact factor: 1.690

4.  Gamma camera emission tomography. Development and properties of a multi-sectional emission computed tomography system.

Authors:  S A Larsson
Journal:  Acta Radiol Suppl       Date:  1980

5.  Determination of regional cerebral blood flow by inhalation of 133-Xenon.

Authors:  W D Obrist; H K Thompson; C H King; H S Wang
Journal:  Circ Res       Date:  1967-01       Impact factor: 17.367

6.  Technetium-99m-d, 1-HM-PAO: a new radiopharmaceutical for imaging regional brain perfusion using SPECT--a comparison with iodine-123 HIPDM.

Authors:  J P Leonard; D P Nowotnik; R D Neirinckx
Journal:  J Nucl Med       Date:  1986-12       Impact factor: 10.057

7.  Quantitative organ visualization using SPECT.

Authors:  L T Kircos; J E Carey; J W Keyes
Journal:  J Nucl Med       Date:  1987-03       Impact factor: 10.057

8.  Scintigraphic measurement of left-ventricular volumes from the count-density distribution.

Authors:  O Nickel; N Schad; E J Andrews; J W Fleming; M Mello
Journal:  J Nucl Med       Date:  1982-05       Impact factor: 10.057

9.  Technetium-99m HM-PAO stereoisomers as potential agents for imaging regional cerebral blood flow: human volunteer studies.

Authors:  P F Sharp; F W Smith; H G Gemmell; D Lyall; N T Evans; D Gvozdanovic; J Davidson; D A Tyrrell; R D Pickett; R D Neirinckx
Journal:  J Nucl Med       Date:  1986-02       Impact factor: 10.057

10.  Regional quantitative noninvasive assessment of cerebral perfusion and function with N-isopropyl-[123I]p-iodoamphetamine.

Authors:  G K von Schulthess; E Ketz; P A Schubiger; A Bekier
Journal:  J Nucl Med       Date:  1985-01       Impact factor: 10.057

View more
  7 in total

1.  99mTc-hexamethylpropylene amine oxime SPECT and X-ray CT in acute cerebral ischaemia.

Authors:  M Feldmann; E Voth; D Dressler; T Henze; K Felgenhauer
Journal:  J Neurol       Date:  1990-12       Impact factor: 4.849

2.  Brain perfusion with intracarotid injection of 99mTc-HM-PAO in partial epilepsy during amobarbital testing.

Authors:  S O Hietala; H Silfvenius; J Aasly; M Olivecrona; L Jonsson
Journal:  Eur J Nucl Med       Date:  1990

3.  Quantitative analysis of 99mTc-HMPAO kinetics in epilepsy.

Authors:  J T Kuikka; E Länsimies; E O Kuikka
Journal:  Eur J Nucl Med       Date:  1990

4.  Quantification of technetium-99m hexamethylpropylene amine oxime brain uptake in routine clinical practice using calibrated point sources as an external standard: phantom and human studies.

Authors:  A Dobbeleir; R Dierckx
Journal:  Eur J Nucl Med       Date:  1993-08

5.  Parameters influencing SPET regional brain uptake of technetium-99m hexamethylpropylene amine oxine measured by calibrated point sources as an external standard.

Authors:  R A Dierckx; A Dobbeleir; M Maes; B A Pickut; A Vervaet; P P De Deyn
Journal:  Eur J Nucl Med       Date:  1994-06

6.  99mTc-HMPAO-SPECT in the diagnosis of senile dementia of Alzheimer's type--a study under clinical routine conditions.

Authors:  G Stoppe; J Staedt; A Kögler; R Schütze; H J Kunert; D Sandrock; D L Munz; D Emrich; E Rüther
Journal:  J Neural Transm Gen Sect       Date:  1995

7.  Relation of left ventricular hypertrophy to regional cerebral blood flow: single photon emission computed tomography abnormalities in essential hypertension.

Authors:  Cristina Sierra; Alejandro de la Sierra; Francisco Lomeña; Juan Carlos Paré; María Larrousse; Antonio Coca
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-10       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.